Rarity Bioscience Alternatives & Competitors
12 companies similar to Rarity Bioscience — Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mu...
Companies similar to Rarity Bioscience
Predicine
Advancing precision medicine through next-generation liquid biopsy oncology platform
Hayward, United States
Invivoscribe
Improving Lives with Precision Diagnostics®
San Diego, United States
-logo.jpg "Foresight Diagnostics (a Natera company)"){kind=logo}
Foresight Diagnostics (a Natera company)
Precision medicine company dedicated to improving the lives of cancer patients through imp...
Boulder, United States
RhoDx, Inc.
Reducing Cancer Morbidity and Mortality through Early Detection and Monitoring.
United States
Track all Rarity Bioscience competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Geneseeq Technology Inc.
Cancer: a word, not a sentence!
Toronto, Canada
BLINK AG
A new era of diagnostics. Rapid, ultraplex, microfluidics-free digital PCR.
Jena, Germany
Adaptive Biotechnologies Corp.
Every immune system has a story to tell; the key is knowing how to listen.
Seattle, United States
TwinStrand Biosciences
Ultra-rare variants are detected with unparalleled sensitivity and specificity with TwinSt...
Exosome Diagnostics, a Bio-Techne brand
ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HG...
Waltham, United States
Biocept, Inc.
Helping physicians improve outcomes for metastatic cancer patients by delivering advanced...
San Diego, United States
Roche
A healthy Sweden, where all knowledge is put to use.
Solna, Switzerland
Personalis, Inc.
Ultrasensitive ctDNA testing
Fremont, United States
About Rarity Bioscience
Rarity Bioscience is a Swedish biotech startup founded in 2021 with a focus on ultra-sensitive and multiplex nucleic acid assays for fast and cost-efficient mutation detection in liquid biopsies. Their precision diagnostics technology, based on a discovery by Dr. Lei Chen, PhD, offers high sensitivity, enabling patient...
Precision Diagnostics, Nucleic Acid Assays, Mutation Detection, Liquid Biopsies, Cancer Diagnostics, MRD (Minimal Residual Disease), Clinical Trials, Oncology Research, Molecular Diagnostics, Biological Sample Analysis, Laboratory Services, Flow Cytometry, Pharmaceutical Research, Medical Technology
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Rarity Bioscience and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Rarity Bioscience on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
